AAPG
Ascentage Pharma Group International
NASDAQ: AAPG · HEALTHCARE · BIOTECHNOLOGY
$22.88
+1.76% today
Updated 2026-04-30
Market cap
$2.15B
P/E ratio
—
P/S ratio
3.74x
EPS (TTM)
$-2.04
Dividend yield
—
52W range
$19 – $48
Volume
0.0M
Ascentage Pharma Group International (AAPG) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|
| Total assets | $593.34M | $581.66M | $1.23B | $1.21B | $1.73B | $2.94B | $2.83B | $2.50B | $2.62B |
| Cash & equivalents | — | — | — | — | — | — | — | — | — |
| Current assets | $463.70M | $414.71M | $990.22M | $909.11M | $1.08B | $1.89B | $1.64B | $1.34B | $1.47B |
| Total liabilities | $607.95M | $713.46M | $2.24B | $314.57M | $884.42M | $1.71B | $2.42B | $2.43B | $2.34B |
| Current liabilities | $77.62M | $79.53M | $105.27M | $202.06M | $276.15M | $361.11M | $881.15M | $934.17M | $1.17B |
| Long-term debt | — | — | — | — | $473.06M | $1.03B | $1.27B | $1.17B | $868.64M |
| Shareholder equity | — | — | — | — | — | — | — | — | — |
| Retained earnings | — | — | $-615.82M | $-2.10B | $-2.77B | $-3.56B | $-4.44B | $-5.37B | $-5.77B |
| Accounts receivable | $8.31M | $7.85M | $5.25M | $2.53M | $480000.00 | $54.13M | $61.49M | $163.54M | $99.07M |
| Inventory | — | — | — | — | $0.00 | $3.93M | $9.45M | $16.17M | $6.60M |
| Goodwill | $24.69M | $24.69M | $24.69M | $24.69M | $24.69M | $24.69M | $24.69M | $24.69M | $24.69M |